Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.900
+0.030 (1.60%)
May 14, 2025, 9:42 AM - Market open
Celularity Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 0.74 | 0.23 | 13.97 | 37.24 | 54.31 | Upgrade
|
| Cash & Short-Term Investments | 0.74 | 0.23 | 13.97 | 37.24 | 54.31 | Upgrade
|
| Cash Growth | 225.11% | -98.38% | -62.50% | -31.43% | 93.08% | Upgrade
|
| Accounts Receivable | 13.56 | 10.05 | 4.45 | 2.75 | 1.13 | Upgrade
|
| Receivables | 13.56 | 12.12 | 6.97 | 5.23 | 6.55 | Upgrade
|
| Inventory | 5.41 | 5.75 | 5.31 | 9.55 | 3.85 | Upgrade
|
| Prepaid Expenses | 0.86 | 1.37 | 6.21 | 4.67 | 6.58 | Upgrade
|
| Other Current Assets | - | 0.33 | 1.05 | 2.41 | 0.87 | Upgrade
|
| Total Current Assets | 20.56 | 19.79 | 33.5 | 59.1 | 72.16 | Upgrade
|
| Property, Plant & Equipment | 72.43 | 78.82 | 88.72 | 90.63 | 90.08 | Upgrade
|
| Goodwill | 7.35 | 7.35 | 119.69 | 123.3 | 123.3 | Upgrade
|
| Other Intangible Assets | 9.25 | 11 | 120.99 | 123.19 | 125.38 | Upgrade
|
| Other Long-Term Assets | 23.1 | 26.93 | 38.16 | 17.91 | 20.09 | Upgrade
|
| Total Assets | 132.68 | 143.89 | 401.07 | 414.13 | 431.01 | Upgrade
|
| Accounts Payable | 23.3 | 14.14 | 5.81 | 9.32 | 5.39 | Upgrade
|
| Accrued Expenses | 19.84 | 8.42 | 13.45 | 7.34 | 10.5 | Upgrade
|
| Short-Term Debt | 6.36 | 39.24 | 37.6 | - | - | Upgrade
|
| Current Portion of Leases | - | - | - | 3.05 | 3.01 | Upgrade
|
| Current Unearned Revenue | 3.53 | 2.83 | 2.27 | 2.2 | 4.83 | Upgrade
|
| Other Current Liabilities | 0.65 | 2.66 | 2.95 | 4.32 | 2.95 | Upgrade
|
| Total Current Liabilities | 53.68 | 67.3 | 62.09 | 26.23 | 26.68 | Upgrade
|
| Long-Term Debt | 35.93 | - | - | - | - | Upgrade
|
| Long-Term Leases | 26.55 | 26.18 | 27.99 | 28.09 | 27.63 | Upgrade
|
| Long-Term Unearned Revenue | 2.72 | 3.19 | 2.22 | 1.87 | 7.62 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Other Long-Term Liabilities | 4.96 | 6.26 | 109.86 | 258.52 | 350.36 | Upgrade
|
| Total Liabilities | 123.85 | 102.93 | 202.17 | 314.71 | 412.3 | Upgrade
|
| Common Stock | 0 | 0.02 | 0.02 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 908.52 | 882.73 | 844.37 | 763.09 | 32.42 | Upgrade
|
| Retained Earnings | -899.68 | -841.79 | -645.5 | -663.68 | -563.56 | Upgrade
|
| Treasury Stock | - | - | - | - | -0.26 | Upgrade
|
| Comprehensive Income & Other | -0.01 | - | 0.01 | - | - | Upgrade
|
| Total Common Equity | 8.84 | 40.96 | 198.9 | 99.42 | -531.4 | Upgrade
|
| Shareholders' Equity | 8.84 | 40.96 | 198.9 | 99.42 | 18.71 | Upgrade
|
| Total Liabilities & Equity | 132.68 | 143.89 | 401.07 | 414.13 | 431.01 | Upgrade
|
| Total Debt | 68.84 | 65.42 | 65.59 | 31.14 | 30.64 | Upgrade
|
| Net Cash (Debt) | -68.1 | -65.19 | -51.62 | 6.1 | 23.67 | Upgrade
|
| Net Cash Growth | - | - | - | -74.21% | 35762.12% | Upgrade
|
| Net Cash Per Share | -3.11 | -3.66 | -3.45 | 0.91 | 12.85 | Upgrade
|
| Filing Date Shares Outstanding | 23.95 | 21.98 | 16.5 | 13.77 | 23.99 | Upgrade
|
| Total Common Shares Outstanding | 19.38 | 19.38 | 14.89 | 12.43 | 23.99 | Upgrade
|
| Working Capital | -33.12 | -47.51 | -28.59 | 32.88 | 45.48 | Upgrade
|
| Book Value Per Share | 0.46 | 2.11 | 13.36 | 8.00 | -22.15 | Upgrade
|
| Tangible Book Value | -7.76 | 22.61 | -41.79 | -147.07 | -780.08 | Upgrade
|
| Tangible Book Value Per Share | -0.40 | 1.17 | -2.81 | -11.83 | -32.52 | Upgrade
|
| Buildings | - | - | - | 12.51 | 12.51 | Upgrade
|
| Machinery | - | 21.87 | 22.21 | 19.37 | 9.59 | Upgrade
|
| Construction In Progress | - | 0.02 | 3.66 | 2.05 | 19.77 | Upgrade
|
| Leasehold Improvements | - | 73.21 | 70.11 | 71.47 | 55.29 | Upgrade
|
Updated Dec 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.